Definition/General

Introduction:
-Caseating lymphadenitis is characterized by granulomatous inflammation with central caseous necrosis resembling cheese in appearance and consistency
-It is most commonly caused by Mycobacterium tuberculosis and represents a hallmark of chronic granulomatous infections
-The caseous necrosis results from inability to completely eliminate the causative organism leading to tissue destruction.
Origin:
-Primarily caused by Mycobacterium tuberculosis complex (M
-tuberculosis, M
-bovis, M
-africanum)
-Atypical mycobacteria (M
-avium-intracellulare, M
-scrofulaceum)
-Fungal infections (Histoplasma capsulatum, Coccidioides immitis)
-Other bacterial infections (Nocardia, Actinomyces)
-Parasitic infections rarely
-Hematogenous spread from pulmonary focus
-Lymphatic spread from local infection.
Classification:
-Classified by causative organism: Tuberculous caseating lymphadenitis (most common)
-Atypical mycobacterial caseating lymphadenitis
-Fungal caseating lymphadenitis
-Other bacterial causes
-By stage: Early granulomatous (minimal necrosis)
-Established caseating (prominent caseous necrosis)
-Advanced fibrocaseous (extensive fibrosis and calcification).
Epidemiology:
-High prevalence in developing countries with endemic tuberculosis
-India has highest burden globally
-Bimodal age distribution: children (5-15) and young adults (20-40)
-HIV co-infection dramatically increases risk
-Immunocompromised patients susceptible to atypical mycobacteria
-Geographic clustering in high TB prevalence areas.

Clinical Features

Presentation:
-Chronic, painless lymphadenopathy with slow progression
-Cervical lymph nodes most commonly affected (60-70%)
-Matted lymph node masses in advanced cases
-Cold abscess formation (fluctuant, non-tender)
-Sinus tract formation with chronic discharge
-Constitutional symptoms (fever, weight loss, night sweats)
-Pulmonary symptoms if concurrent lung involvement.
Symptoms:
-Low-grade fever (intermittent pattern)
-Night sweats and weight loss
-Chronic fatigue and malaise
-Anorexia
-Chronic cough (pulmonary TB)
-Hemoptysis (advanced pulmonary disease)
-Chest pain (pleural involvement)
-Dysphagia (mediastinal lymphadenopathy).
Risk Factors:
-HIV infection (20-fold increased risk)
-Immunosuppressive therapy (corticosteroids, TNF-α inhibitors)
-Malnutrition and protein-energy malnutrition
-Diabetes mellitus
-Chronic kidney disease
-Household TB contact
-Overcrowding and poor ventilation
-Alcohol abuse and smoking.
Screening:
-Tuberculin skin test (TST) or Interferon-gamma release assays (IGRA)
-Chest X-ray and CT thorax
-Sputum examination (AFB smear, culture, GeneXpert)
-Fine needle aspiration cytology
-Histopathological examination
-Culture and drug susceptibility testing
-HIV testing mandatory.

Master Caseating Lymphadenitis Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Enlarged lymph nodes with thick, adherent capsule
-Cut surface reveals yellow-white caseous material (cheese-like consistency)
-Central caseous necrosis surrounded by gray-white tissue
-Calcification in chronic cases (gritty consistency)
-Matted lymph node complexes
-Cold abscess formation with fluctuant areas.
Characteristics:
-Firm to fluctuant consistency depending on stage
-Caseous material has thick, paste-like consistency
-No true suppuration (distinguishes from bacterial abscess)
-Calcific deposits in healed lesions
-Fibrotic capsule thickening
-Adherence to surrounding structures
-Sinus tract extension to skin.
Size Location:
-Variable size from 1-10 cm
-Cervical lymph nodes (posterior triangle most common)
-Mediastinal and hilar lymph nodes (25% of cases)
-Axillary lymph nodes (10-15%)
-Abdominal lymph nodes (mesenteric, para-aortic)
-Multiple anatomical sites in disseminated disease.
Multifocality:
-Regional involvement following lymphatic drainage
-Bilateral cervical involvement in advanced cases
-Mediastinal spread from cervical disease
-Generalized lymphadenopathy in miliary TB
-Associated organ involvement (lungs, pleura, peritoneum)
-Skip lesions possible.

Microscopic Description

Histological Features:
-Epithelioid granulomas with central caseous necrosis
-Caseous necrosis appears as homogeneous, eosinophilic, structureless material
-Epithelioid cells surrounding necrotic center
-Langhans giant cells with horseshoe-shaped nuclear arrangement
-Chronic inflammatory cells at periphery
-Fibrosis and calcification in chronic stages.
Cellular Characteristics:
-Epithelioid cells (activated macrophages) with elongated nuclei
-Langhans giant cells with peripheral nuclear arrangement
-Caseous necrosis with complete loss of cellular architecture
-Lymphocytes and plasma cells at granuloma periphery
-Fibroblasts and collagen deposition
-Rare acid-fast bacilli (AFB) in tissue sections.
Architectural Patterns:
-Confluent granulomas with extensive caseous necrosis
-Complete architectural effacement in advanced cases
-Zonal pattern: central necrosis, epithelioid cells, lymphocytes, fibrosis
-Capsular involvement with pericapsular extension
-Calcification pattern in healed disease
-Fibrotic scarring replacement.
Grading Criteria:
-Extent of caseous necrosis (focal, extensive, complete)
-Granuloma maturity (well-formed vs poorly formed)
-Degree of fibrosis and calcification
-Organism load (AFB density)
-Activity assessment (epithelioid cell morphology)
-Healing vs active disease patterns.

Immunohistochemistry

Positive Markers:
-CD68 positive in epithelioid cells and giant cells
-CD163 positive in M2 macrophages
-Lysozyme positive in epithelioid cells
-CD3 highlights peripheral T-lymphocytes
-CD20 shows B-cells in preserved areas
-Smooth muscle actin may be positive in epithelioid cells
-Ki-67 low in granulomatous areas.
Negative Markers:
-CD1a and Langerin negative (excludes Langerhans cell histiocytosis)
-CD30 negative (excludes lymphoma)
-Cytokeratin negative in epithelioid cells
-S-100 negative in most cells
-Melanoma markers negative
-CD21 and CD23 highlight compressed FDC networks.
Diagnostic Utility:
-Acid-fast bacilli (AFB) staining essential (Ziehl-Neelsen, Auramine-Rhodamine)
-CD68 staining confirms histiocytic nature
-Immunohistochemistry limited for TB diagnosis
-PCR-based methods more sensitive
-GeneXpert MTB/RIF for rapid diagnosis
-Culture remains gold standard for definitive diagnosis.
Molecular Subtypes:
-Drug-sensitive tuberculosis
-Multidrug-resistant TB (MDR-TB) (isoniazid + rifampin resistant)
-Extensively drug-resistant TB (XDR-TB)
-Atypical mycobacterial species identification
-Rapid molecular testing for resistance patterns
-Whole genome sequencing for comprehensive profiling.

Molecular/Genetic

Genetic Mutations:
-Mycobacterial resistance mutations (rpoB, katG, gyrA genes)
-Host genetic susceptibility (HLA associations, NRAMP1)
-Vitamin D receptor polymorphisms
-TNF-α gene variants
-IL-10 promoter polymorphisms
-Complement component deficiencies
-Primary immunodeficiency genes.
Molecular Markers:
-Mycobacterial DNA by PCR (IS6110, 16S rRNA)
-GeneXpert MTB/RIF for rapid diagnosis
-Line probe assays for drug resistance
-Interferon-γ release assays
-TNF-α essential for granuloma maintenance
-IL-12 and IL-23 in Th1 response
-Complement activation products.
Prognostic Significance:
-Excellent prognosis with appropriate anti-TB therapy (>95% cure rate)
-Drug-resistant TB has prolonged treatment and worse outcomes
-HIV co-infection increases mortality risk
-Delayed diagnosis leads to complications
-Immune reconstitution inflammatory syndrome (IRIS) in HIV patients
-Complete healing with calcification typical.
Therapeutic Targets:
-First-line anti-TB drugs: isoniazid, rifampin, ethambutol, pyrazinamide (HRZE)
-Treatment duration: 6 months for drug-sensitive TB
-Second-line drugs for resistant cases
-Directly observed therapy (DOTS)
-Drug susceptibility testing guided therapy
-Surgical intervention for complications
-Contact tracing and prevention.

Differential Diagnosis

Similar Entities:
-Sarcoidosis (non-caseating granulomas)
-Fungal lymphadenitis (histoplasmosis, coccidioidomycosis)
-Atypical mycobacterial infection
-Cat scratch disease (stellate abscesses)
-Malignancy with sarcoid-like reaction
-Foreign body reaction
-Other granulomatous conditions.
Distinguishing Features:
-Caseating lymphadenitis: caseous necrosis, Langhans giants, AFB positive, endemic areas
-Sarcoidosis: non-caseating granulomas, bilateral hilar lymphadenopathy, elevated ACE
-Histoplasmosis: organisms in macrophages, GMS positive, endemic regions
-Cat scratch: stellate abscesses, neutrophils, Warthin-Starry positive
-Sarcoid reaction: underlying malignancy, non-caseating pattern.
Diagnostic Challenges:
-Paucibacillary disease with negative AFB stains
-Atypical presentations in immunocompromised patients
-Culture-negative cases requiring molecular methods
-Mixed infections (TB + other organisms)
-Drug-resistant organisms affecting treatment response
-Immune reconstitution paradoxical reactions.
Rare Variants:
-Miliary tuberculosis with disseminated lymphadenopathy
-Scrofula (cervical TB in children)
-Tuberculous lymphadenitis in HIV
-Post-primary tuberculosis
-Multidrug-resistant tuberculosis
-Immune reconstitution syndrome
-Calcified tuberculous lymph nodes
-Atypical mycobacterial lymphadenitis.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

Lymph node biopsy from [cervical/mediastinal/other] region, measuring [X.X] cm, with caseous consistency

Diagnosis

Caseating granulomatous lymphadenitis, consistent with mycobacterial infection

Stage Classification

Stage: [granulomatous/caseating/fibrocaseous], activity: [active/chronic/healing]

Histological Features

Shows [epithelioid granulomas] with [central caseous necrosis] and [Langhans giant cells]

Size and Necrosis

Size: [X.X] cm, caseous necrosis: [extensive/focal], granulomas: [well-formed/confluent]

Organism Detection

AFB stain: [positive/negative], PCR/GeneXpert: [positive/negative for MTB], resistance: [pattern if detected]

Special Studies

AFB stain: [positive/negative for acid-fast bacilli], morphology: [description]

GeneXpert MTB/RIF: [positive/negative], rifampin resistance: [detected/not detected]

Culture: [positive/negative/pending for M. tuberculosis], drug sensitivity: [pattern]

Final Diagnosis

Caseating granulomatous lymphadenitis, [drug-sensitive/drug-resistant] tuberculosis, requiring anti-TB therapy